Clinical Research Studies

The purpose of this study is to determine if the study drug called ALZ-801 is safe, if it is well tolerated (how your body reacts to the study drug) and if it is effective in treating Alzheimer’s Disease (AD). ALZ-801 has an active agent called tramiprosate, which interferes with the formation of abnormal forms of a protein called beta amyloid or Aß-42. These abnormal amyloid proteins are thought to play an important role in causing cell damage in the brain and the development of AD. ALZ-801 inhibits the formation of these abnormal toxic proteins and may be able to slow down or stop the worsening of AD. To determine if ALZ-801 is effective, a comparison must be made between ALZ-801 and placebo. A placebo looks like the study drug but does not contain any active drug. Researchers use a placebo to see if a study drug works better or is safer than not taking anything at all.